Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > From Clinical Trials to Real Life: Impact of Elexacaftor/Tezacaftor/Ivacaftor in the United Kingdom

From Clinical Trials to Real Life: Impact of Elexacaftor/Tezacaftor/Ivacaftor in the United Kingdom

Resource Type

CF Research News

Authors

Gabriela Vega-Hernandez, Gordon MacGregor, Andrew Wilfin, Francis Adams, Ciarán Haugh, Carl A. Baxter, Heike Wöhling, Sarah L. Clarke, Susan C. Charman, Siobhán B. Carr

References

J Cyst Fibros. 2025 May 15:S1569-1993(25)01467-5.  doi: 10.1016/j.jcf.2025.04.012

Document

File JCF-D-24-00481R3_FINAL_Vega-Hernandez_200725.docx [1]

Keywords

Cystic fibrosis [2]
Elexacaftor [3]
Ivacaftor [4]
Real-world [5]
registry [6]
Tezacaftor [7]

Date

Monday, May 5, 2025

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [8]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/clinical-trials-real-life-impact-elexacaftortezacaftorivacaftor

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-24-00481R3_FINAL_Vega-Hernandez_200725.docx [2] https://www.ecfs.eu/research-article-keywords/cystic-fibrosis [3] https://www.ecfs.eu/research-article-keywords/elexacaftor [4] https://www.ecfs.eu/research-article-keywords/ivacaftor [5] https://www.ecfs.eu/research-article-keywords/real-world [6] https://www.ecfs.eu/research-article-keywords/registry [7] https://www.ecfs.eu/research-article-keywords/tezacaftor [8] https://www.ecfs.eu/resource-guideline-type/other-guidelines